Search research articles

Search research articles

Related Experiment Videos

Primary sclerosing cholangitis. An unresolved enigma.

P L Jansen¹, J B Sanders

¹Division of Hepatogastroenterology, Academic Medical Center, Amsterdam, The Netherlands.

Scandinavian Journal of Gastroenterology. Supplement

|January 1, 1992

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Treatment of dementia].

Nederlands tijdschrift voor geneeskunde·2017

Same author

Effect of obeticholic acid on liver regeneration following portal vein embolization in an experimental model.

The British journal of surgery·2017

Same author

Effect and side-effects of alpha interferon treatment in haemophilia patients with chronic hepatitis C.

Haemophilia : the official journal of the World Federation of Hemophilia·2016

Same author

Evaluation of a risk assessment questionnaire to assist hepatitis C screening in the general population.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2010

Same author

Impact of mesh positioning on foreign body reaction and collagenous ingrowth in a rabbit model of open incisional hernia repair.

Hernia : the journal of hernias and abdominal wall surgery·2009

Same author

[Frontal syndrome. A patient with a recognisable clinical picture but without a clear aetiology. A case study].

Tijdschrift voor psychiatrie·2007

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Primary sclerosing cholangitis (PSC) is a bile duct disease often linked to inflammatory bowel disease. While ursodeoxycholic acid improves symptoms, liver transplantation offers a significant survival benefit for PSC patients.

Area of Science:

Gastroenterology and Hepatology
Immunology
Genetics

Background:

Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease affecting intra- and extra-hepatic bile ducts.
PSC is frequently associated with inflammatory bowel disease (IBD) and specific autoimmune haplotypes like HLA-A1, B8, and DR3.
The exact etiology of PSC remains unknown, but autoimmune factors are implicated.

Purpose of the Study:

To summarize the diagnostic methods, clinical characteristics, and treatment outcomes for primary sclerosing cholangitis.
To evaluate the prognostic factors and survival rates in patients with PSC.
To review current therapeutic strategies and their efficacy in managing PSC.

Main Methods:

Diagnosis relies on endoscopic retrograde cholangiography (ERC) and liver biopsy to assess bile duct strictures and rule out secondary cirrhosis.

Related Experiment Videos

Patient data from a series of 50 individuals were analyzed to determine 5-year survival rates.

Serological markers, including antibodies to perinuclear antigens in leukocytes, were assessed.

Main Results:

The 5-year survival rate for PSC patients was 85%.
Antibodies to perinuclear antigens were detected in 65% of patients.
Ursodeoxycholic acid therapy demonstrated improvement in symptoms and liver enzyme levels.
Liver transplantation showed a 4-year survival rate of 88%.

Conclusions:

PSC is a serious bile duct disease with significant associations with IBD and autoimmune markers.
While ursodeoxycholic acid offers symptomatic relief, effective treatments for fibrosis and cirrhosis are lacking.
Liver transplantation is a viable and effective treatment option for advanced PSC, offering substantial long-term survival.